Your browser doesn't support javascript.
loading
Prosaposin is a regulator of progranulin levels and oligomerization.
Nicholson, Alexandra M; Finch, NiCole A; Almeida, Marcio; Perkerson, Ralph B; van Blitterswijk, Marka; Wojtas, Aleksandra; Cenik, Basar; Rotondo, Sergio; Inskeep, Venette; Almasy, Laura; Dyer, Thomas; Peralta, Juan; Jun, Goo; Wood, Andrew R; Frayling, Timothy M; Fuchsberger, Christian; Fowler, Sharon; Teslovich, Tanya M; Manning, Alisa K; Kumar, Satish; Curran, Joanne; Lehman, Donna; Abecasis, Goncalo; Duggirala, Ravindranath; Pottier, Cyril; Zahir, Haaris A; Crook, Julia E; Karydas, Anna; Mitic, Laura; Sun, Ying; Dickson, Dennis W; Bu, Guojun; Herz, Joachim; Yu, Gang; Miller, Bruce L; Ferguson, Shawn; Petersen, Ronald C; Graff-Radford, Neill; Blangero, John; Rademakers, Rosa.
Afiliação
  • Nicholson AM; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA.
  • Finch NA; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA.
  • Almeida M; South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, Texas 78520, USA.
  • Perkerson RB; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA.
  • van Blitterswijk M; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA.
  • Wojtas A; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA.
  • Cenik B; Department of Neuroscience, Molecular Genetics, and Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
  • Rotondo S; Department of Cell Biology and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
  • Inskeep V; Division of Human Genetics, Cincinnati Children's Hospital Research Foundation, Cincinnati, Ohio 45229, USA.
  • Almasy L; South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, Texas 78520, USA.
  • Dyer T; South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, Texas 78520, USA.
  • Peralta J; South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, Texas 78520, USA.
  • Jun G; Human Genetics Center, School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas 77030, USA.
  • Wood AR; Genetics of Complex Traits, St Luke's Campus, University of Exeter Medical School, University of Exeter, Exeter EX1 2LU, UK.
  • Frayling TM; Genetics of Complex Traits, St Luke's Campus, University of Exeter Medical School, University of Exeter, Exeter EX1 2LU, UK.
  • Fuchsberger C; Department of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan 48109, USA.
  • Fowler S; Department of Medicine, University of Texas Health Science Center, San Antonio, Texas 78229, USA.
  • Teslovich TM; Department of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan 48109, USA.
  • Manning AK; Center for Human Genetics Research, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
  • Kumar S; South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, Texas 78520, USA.
  • Curran J; South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, Texas 78520, USA.
  • Lehman D; Department of Medicine/Cardiology and Cellular &Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA.
  • Abecasis G; Department of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan 48109, USA.
  • Duggirala R; South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, Texas 78520, USA.
  • Pottier C; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA.
  • Zahir HA; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA.
  • Crook JE; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA.
  • Karydas A; Memory and Aging Center, Department of Neurology, University of California, San Francisco, California 94143, USA.
  • Mitic L; Memory and Aging Center, Department of Neurology, University of California, San Francisco, California 94143, USA.
  • Sun Y; Division of Human Genetics, Cincinnati Children's Hospital Research Foundation, Cincinnati, Ohio 45229, USA.
  • Dickson DW; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA.
  • Bu G; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA.
  • Herz J; Department of Molecular Genetics, Neuroscience, Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
  • Yu G; Department of Molecular Genetics, Neuroscience, Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
  • Miller BL; Memory and Aging Center, Department of Neurology, University of California, San Francisco, California 94143, USA.
  • Ferguson S; Department of Cell Biology and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
  • Petersen RC; Department of Neurology, Mayo Clinic, Rochester, Minnesota 55902, USA.
  • Graff-Radford N; Department of Neurology, Mayo Clinic, Jacksonville, Florida 32224, USA.
  • Blangero J; South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, Texas 78520, USA.
  • Rademakers R; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA.
Nat Commun ; 7: 11992, 2016 06 30.
Article em En | MEDLINE | ID: mdl-27356620
ABSTRACT
Progranulin (GRN) loss-of-function mutations leading to progranulin protein (PGRN) haploinsufficiency are prevalent genetic causes of frontotemporal dementia. Reports also indicated PGRN-mediated neuroprotection in models of Alzheimer's and Parkinson's disease; thus, increasing PGRN levels is a promising therapeutic for multiple disorders. To uncover novel PGRN regulators, we linked whole-genome sequence data from 920 individuals with plasma PGRN levels and identified the prosaposin (PSAP) locus as a new locus significantly associated with plasma PGRN levels. Here we show that both PSAP reduction and overexpression lead to significantly elevated extracellular PGRN levels. Intriguingly, PSAP knockdown increases PGRN monomers, whereas PSAP overexpression increases PGRN oligomers, partly through a protein-protein interaction. PSAP-induced changes in PGRN levels and oligomerization replicate in human-derived fibroblasts obtained from a GRN mutation carrier, further supporting PSAP as a potential PGRN-related therapeutic target. Future studies should focus on addressing the relevance and cellular mechanism by which PGRN oligomeric species provide neuroprotection.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos e Proteínas de Sinalização Intercelular / Saposinas / Demência Frontotemporal Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Commun Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos e Proteínas de Sinalização Intercelular / Saposinas / Demência Frontotemporal Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Commun Ano de publicação: 2016 Tipo de documento: Article